{"nctId":"NCT00680225","briefTitle":"Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma","startDateStruct":{"date":"2007-09"},"conditions":["Choroidal Melanoma"],"count":10,"armGroups":[{"label":"Lucentis Injection","type":"EXPERIMENTAL","interventionNames":["Drug: Ranibizumab injection and TTT - ICG based"]}],"interventions":[{"name":"Ranibizumab injection and TTT - ICG based","otherNames":["Lucentis injection"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\> 18 yo.\n* Primary pigmented or amelanotic choroidal melanoma measurement of 16 mm or less in the largest vessel diameter and 6 mm or less in the apical height.\n* Location of the tumor posterior to the equator.\n* Documented growth by A/B scan.\n* Risk factor for metastasis (thickness greater than 2 mm, symptoms, tumor margin at the optic disc)\n* Ability to provide inform consent.\n* Comply with the study assessment for the cooperation of the study.\n\nExclusion Criteria:\n\n* Pregnancy or lactation.\n* Premenopausal women not using adequate contraception; surgical sterilization or use of oral contraception, barrier contraception with either a condom or diaphragm or in conjunction with spermicidal gel, an IUD or contraceptive hormon implant or patch.\n* Current infection or inflammation in either eye.\n* Extension of tumor into the orbit.\n* Retinal spread or metastatic disease.\n* Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated.\n* Any known allergy to any of the components to be used in the study.\n* Participation in another simultaneous medical investigation or trial.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Tumor Thickness","description":null,"paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.91","spread":null}]}]}]},{"type":"SECONDARY","title":"Visual Acuity Changes","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}